These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 9373158)
1. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. Walsh AH; Cheng A; Honkanen RE FEBS Lett; 1997 Oct; 416(3):230-4. PubMed ID: 9373158 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors. Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665 [TBL] [Abstract][Full Text] [Related]
3. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity. Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869 [TBL] [Abstract][Full Text] [Related]
4. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Weinbrenner C; Baines CP; Liu GS; Armstrong SC; Ganote CE; Walsh AH; Honkanen RE; Cohen MV; Downey JM Circulation; 1998 Sep; 98(9):899-905. PubMed ID: 9738645 [TBL] [Abstract][Full Text] [Related]
5. Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters. Hastie CJ; Cohen PT FEBS Lett; 1998 Jul; 431(3):357-61. PubMed ID: 9714542 [TBL] [Abstract][Full Text] [Related]
6. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855 [TBL] [Abstract][Full Text] [Related]
7. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. Honkanen RE FEBS Lett; 1993 Sep; 330(3):283-6. PubMed ID: 8397101 [TBL] [Abstract][Full Text] [Related]
8. Regulation of immunoglobulin E-mediated secretion by protein phosphatases in human basophils and mast cells of skin and lung. Bastan R; Peirce MJ; Peachell PT Eur J Pharmacol; 2001 Oct; 430(1):135-41. PubMed ID: 11698073 [TBL] [Abstract][Full Text] [Related]
9. Okadaic acid overcomes the blocked cell cycle caused by depleting Cdc2-related kinases in Trypanosoma brucei. Li Z; Tu X; Wang CC Exp Cell Res; 2006 Nov; 312(18):3504-16. PubMed ID: 16949574 [TBL] [Abstract][Full Text] [Related]
10. Positive regulation of IkappaB kinase signaling by protein serine/threonine phosphatase 2A. Kray AE; Carter RS; Pennington KN; Gomez RJ; Sanders LE; Llanes JM; Khan WN; Ballard DW; Wadzinski BE J Biol Chem; 2005 Oct; 280(43):35974-82. PubMed ID: 16126728 [TBL] [Abstract][Full Text] [Related]
11. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors. Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807 [TBL] [Abstract][Full Text] [Related]
12. Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition. Buck SB; Hardouin C; Ichikawa S; Soenen DR; Gauss CM; Hwang I; Swingle MR; Bonness KM; Honkanen RE; Boger DL J Am Chem Soc; 2003 Dec; 125(51):15694-5. PubMed ID: 14677930 [TBL] [Abstract][Full Text] [Related]
14. CRHSP-24 phosphorylation is regulated by multiple signaling pathways in pancreatic acinar cells. Schäfer C; Steffen H; Krzykowski KJ; Göke B; Groblewski GE Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G726-34. PubMed ID: 12801884 [TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia. Armstrong SC; Gao W; Lane JR; Ganote CE J Mol Cell Cardiol; 1998 Jan; 30(1):61-73. PubMed ID: 9500865 [TBL] [Abstract][Full Text] [Related]
16. Role for protein phosphatase 2A in the regulation of Calu-3 epithelial Na+-K+-2Cl-, type 1 co-transport function. Liedtke CM; Wang X; Smallwood ND J Biol Chem; 2005 Jul; 280(27):25491-8. PubMed ID: 15899883 [TBL] [Abstract][Full Text] [Related]
17. Serine/threonine protein phosphatases and a protein phosphatase 1 inhibitor from Neurospora crassa. Zapella PD; da-Silva AM; da-Costa-Maia JC; Terenzi HF Braz J Med Biol Res; 1996 May; 29(5):599-604. PubMed ID: 9033809 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells. Messner DJ; Romeo C; Boynton A; Rossie S J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789 [TBL] [Abstract][Full Text] [Related]
19. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. McCluskey A; Sim AT; Sakoff JA J Med Chem; 2002 Mar; 45(6):1151-75. PubMed ID: 11881984 [No Abstract] [Full Text] [Related]
20. The predicted beta12-beta13 loop is important for inhibition of PP2Acalpha by the antitumor drug fostriecin. Evans DR; Simon JA FEBS Lett; 2001 Jun; 498(1):110-5. PubMed ID: 11389908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]